Therapeutic Asset Ratings

165 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
cd146/her2 car-t cells Sarcoma	Essen Biotech	P1/2	CC (43)
cd22 car-transduced t cells Diffuse Large B-Cell Lymphoma	Essen Biotech	P1/2	CC (43)
Dual-Target Antigen-Selected Car-Nk Non-Small Cell Lung Carcinoma	Essen Biotech	P1/2	CC (43)
Dual-Target Antigen-Selected Car-Nk Pancreatic Ductal Adenocarcinoma	Essen Biotech	P1/2	CC (43)
EBNK-001 Urinary Bladder Carcinoma	Essen Biotech	P1/2	CC (43)
EBNK-001 Kidney Cancer	Essen Biotech	P1/2	CC (43)
EBNK-001 Sarcoma	Essen Biotech	P1/2	CC (43)
Eb-Select Single-Target Car-Nk Cells Non-Small Cell Lung Carcinoma	Essen Biotech	P1/2	CC (43)
Eb-Select Single-Target Car-Nk Cells Pancreatic Ductal Adenocarcinoma	Essen Biotech	P1/2	CC (43)
Fludarabine Metastatic Malignant Neoplasm In The Brain	Essen Biotech	P1/2	CC (43)
Fludarabine Glioma	Essen Biotech	P1/2	CC (43)
il-15 Urinary Bladder Carcinoma	Essen Biotech	P1/2	CC (43)
il-15 Kidney Cancer	Essen Biotech	P1/2	CC (43)
il-15 Sarcoma	Essen Biotech	P1/2	CC (43)
TIL Metastatic Malignant Neoplasm In The Brain	Essen Biotech	P1/2	CC (43)
TIL Glioma	Essen Biotech	P1/2	CC (43)
Dual-Target Antigen-Selected Car-Nk Cancer	Essen Biotech	P1/2	CC (41)
Dual-Target Antigen-Selected Car-Nk Glioblastoma	Essen Biotech	P1/2	CC (41)
Dual-Target Antigen-Selected Car-Nk Liver Cancer	Essen Biotech	P1/2	CC (41)
EBNK-001 Cancer	Essen Biotech	P1/2	CC (41)
EBNK-001 Esophageal Cancer	Essen Biotech	P1/2	CC (41)
EBNK-001 Glioblastoma	Essen Biotech	P1/2	CC (41)
Eb-Select Single-Target Car-Nk Cells Cancer	Essen Biotech	P1/2	CC (41)
Eb-Select Single-Target Car-Nk Cells Glioblastoma	Essen Biotech	P1/2	CC (41)
Eb-Select Single-Target Car-Nk Cells Liver Cancer	Essen Biotech	P1/2	CC (41)

Showing 126 to 150 of 165 assets

PreviousPage 6 of 7Next